Treatment of syphilis in HIV-infected subjects: A systematic review of the literature

Sexually Transmitted Infections

Volumn 87, Issue 1, 2011, Pages 9-16

  Blank, Leah J ^a   Rompalo, Anne M ^a   Erbelding, Emily J ^a   Zenilman, Jonathan M ^a   Ghanem, Khalil G ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIINFECTIVE AGENT; AZITHROMYCIN; BENETHAMINE PENICILLIN; BENZATHINE PENICILLIN; CEFTRIAXONE; DOXYCYCLINE; ERYTHROMYCIN; PENICILLIN G; PROBENECID; PROCAINE PENICILLIN; TETRACYCLINE;

ANTIMICROBIAL THERAPY; DRUG EFFICACY; DRUG TREATMENT FAILURE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; MEDICAL LITERATURE; NEUROSYPHILIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYPHILIS; SYPHILIS SEROLOGY; SYSTEMATIC REVIEW;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-BACTERIAL AGENTS; HUMANS; PRACTICE GUIDELINES AS TOPIC; SYPHILIS; TREATMENT OUTCOME;

EID: 78751642638     PISSN: 13684973     EISSN: None     Source Type: Journal    
DOI: 10.1136/sti.2010.043893     Document Type: Review

References (47)

1. Idsoe O, Guthe T, Willcox RR. Penicillin in the treatment of syphilis. The experience of three decades. Bull World Health Organ 1972;47:1-68.
2. Workowski KA, Berman SM; Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2006. MMWR Recomm Rep 2006;55(RR-11):1-94.
3. Lukehart SA, Hook EW 3rd, Baker-Zander SA, et al. Invasion of the central nervous system by Treponema pallidum: implications for diagnosis and treatment. Ann Intern Med 1988;109:855-62.
4. Marra CM, Maxwell CL, Smith SL, et al. Cerebrospinal fluid abnormalities in patients with syphilis: association with clinical and laboratory features. J Infect Dis 2004;189:369-76.
5. Dunlop EM, Al-Egaily SS, Houang ET. Penicillin levels in blood and CSF achieved by treatment of syphilis. JAMA 1979;241:2538-40.
6. Perdrup A, Jorgensen BB, Pedersen NS. The profile of neurosyphilis in Denmark: A clinical and serological study of all patients in Denmark with neurosyphilis disclosed in the years 1971-1979 incl. by Wassermann reaction (CWRM) in the cerebrospinal fluid. Acta Derm Venereol 1981;96:1-14.
7. Berry CD, Hooton TM, Collier AC, et al. Neurologic relapse after benzathine penicillin therapy for secondary syphilis in a patient with HIV infection. N Engl J Med 1987;316:1587-9.
8. Zetola NM, Klausner JD. Syphilis and HIV infection: an update. Clin Infect Dis 2007;44:1222-8.
9. Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996;17:1-12.
10. Dowell ME, Ross PG, Musher DM, et al. Response of latent syphilis or neurosyphilis to ceftriaxone therapy in persons infected with human immunodeficiency virus. Am J Med 1992;93:481-8.
11. Gourevitch MN, Selwyn PA, Davenny K, et al. Effects of HIV infection on the serologic manifestations and response to treatment of syphilis in intravenous drug users. Ann Intern Med 1993;118:350-5.
12. Caumes E, Minta D, Niel G, et al. Syphilis precoce et infection par le VIH: A propos de 13 cas. Med Mal Infect 1994;24:785-91.
13. Gordon SM, Eaton ME, George R, et al. The response of symptomatic neurosyphilis to high-dose intravenous penicillin G in patients with human immunodeficiency virus infection. N Engl J Med 1994;331:1469-73. (Pubitemid 24356304)
14. Hutchinson CM, Hook EW 3rd, Shepherd M, et al. Altered clinical presentation of early syphilis in patients with human immunodeficiency virus infection. Ann Intern Med 1994;121:94-100.
15. Goeman J, Kivuvu M, Nzila N, et al. Similar serological response to conventional therapy for syphilis among HIV-positive and HIV-negative women. Genitourin Med 1995;71:275-9.
16. Malone JL, Wallace MR, Hendrick BB, et al. Syphilis and neurosyphilis in a human immunodeficiency virus type-1 seropositive population: Evidence for frequent serologic relapse after therapy. Am J Med 1995;99:55-63.
17. Marra CM, Longstreth WT Jr, Maxwell CL, et al. Resolution of serum and cerebrospinal fluid abnormalities after treatment of neurosyphilis. Influence of concomitant human immunodeficiency virus infection. Sex Transm Dis 1996;23:184-9.
18. Yinnon AM, Coury-Doniger P, Polito R, et al. Serologic response to treatment of syphilis in patients with HIV infection. Arch Intern Med 1996;156:321-5.
19. Rolfs RT, Joesoef MR, Hendershot EF, et al. A randomized trial of enhanced therapy for early syphilis in patients with and without human immunodeficiency virus infection. The Syphilis and HIV Study Group. N Engl J Med 1997;337:307-14.
20. Bordon J, Martinez-Vazquez C, de la Fuente-Aguado J, et al. Response to standard syphilis treatment in patients infected with the human immunodeficiency virus. Eur J Clin Microbiol Infect Dis 1999;18:729-32.
21. Hook EW 3rd, Martin DH, Stephens J, et al. A randomized, comparative pilot study of azithromycin versus benzathine penicillin G for treatment of early syphilis. Sex Transm Dis 2002;29:486-90.
22. Tattevin P, Renault P, Joly V, et al. Treatment of latent syphilis in HIV-infected patients with 10 d of benzylpenicillin G benethamine: A prospective study in Maputo, Mozambique. Scand J Infect Dis 2002;34:257-61. (Pubitemid 34520668)
23. Smith NH, Musher DM, Huang DB, et al. Response of HIV-infected patients with asymptomatic syphilis to intensive intramuscular therapy with ceftriaxone or procaine penicillin. Int J STD AIDS 2004;15:328-32.
24. Gutierrez-Galhardo MC, do Valle GF, Sa FC, et al. Clinical characteristics and evolution of syphilis in 24 HIV+ individuals in Rio de Janeiro, Brazil. Rev Inst Med Trop Sao Paulo 2005;47:153-7.
25. Kiddugavu MG, Kiwanuka N, Wawer MJ, et al. Effectiveness of syphilis treatment using azithromycin and/or benzathine penicillin in Rakai, Uganda. Sex Transm Dis 2005;32:1-6.
26. Nnoruka EN, Ezeoke AC. Evaluation of syphilis in patients with HIV infection in Nigeria. Trop Med Int Health 2005;10:58-64.
27. Riedner G, Rusizoka M, Todd J, et al. Single-dose azithromycin versus penicillin G benzathine for the treatment of early syphilis. N Engl J Med 2005;353:1236-44. (Pubitemid 41345945)
28. Chauhan M, Serisha B, Sankar KN, et al. Audit of the use of benzathine penicillin, post-treatment syphilis serology and partner notification of patients with early infectious syphilis. Int J STD AIDS 2006;17:200-2. (Pubitemid 43295056)
29. Kofoed K, Gerstoft J, Mathiesen LR, et al. Syphilis and human immunodeficiency virus (HIV)-1 coinfection: influence on CD4 T-cell count, HIV-1 viral load and treatment response. Sex Transm Dis 2006;33:143-8.
30. Ghanem KG, Erbelding EJ, Wiener ZS, et al. Serological response to syphilis treatment in HIV-positive and HIV-negative patients attending sexually transmitted diseases clinics. Sex Transm Infect 2007;83:97-101.
31. Manavi K, McMillan A. The outcome of treatment of early latent syphilis and syphilis with undetermined duration in HIV-infected and HIV-uninfected patients. Int J STD AIDS 2007;18:814-18.
32. Ghanem KG, Moore RD, Rompalo AM, et al. Antiretroviral therapy is associated with reduced serologic failure rates for syphilis among HIV-infected patients. Clin Infect Dis 2008;47:258-65.
33. Should early syphilis be treated differently in HIV positive and HIV negative individuals? Brooklyn, NY. BASHH ASTDA 3rd Joint Conference, Brooklyn, NY, 2008, Abstract E-08.
34. Warwick Z, Dean G, Fisher M. Should syphilis be treated differently in HIV-positive and HIV-negative individuals? Treatment outcomes at a university hospital, Brighton, UK. Int J STD AIDS 2009;20:229-30.
35. Kingston M, French P, Goh B, et al. UK National guidelines on the management of syphilis 2008. Int J STD AIDS 2008;19:729-40.
36. Stamm LV, Bergen HL. A point mutation associated with bacterial macrolide resistance is present in both 23S rRNA genes of an erythromycin-resistant Treponema pallidum clinical isolate. Antimicrob Agents Chemother 2000;44:806-7.
37. Lukehart SA, Godornes C, Molini BJ, et al. Macrolide resistance in Treponema pallidum in the United States and Ireland. N Engl J Med 2004;351:154-8.
38. Matejkova P, Flasarova M, Zakoucka H, et al. Macrolide treatment failure in a case of secondary syphilis: a novel A2059G mutation in the 23S rRNA gene of Treponema pallidum subsp. pallidum. J Med Microbiol 2009;58:832-6.
39. Romanowski B, Sutherland R, Fick GH, et al. Serologic response to treatment of infectious syphilis. Ann Intern Med 1991;114:1005-9.
40. Marra CM, Maxwell CL, Collier AC, et al. Interpreting cerebrospinal fluid pleocytosis in HIV in the era of potent antiretroviral therapy. BMC Infect Dis 2007;7:37.
41. De Milito A. B lymphocyte dysfunctions in HIV infection. Curr HIV Res 2004;2:11-21.
42. Marra CM. Déjà Vu all over again: When to perform a lumbar puncture in HIVinfected patients with syphilis. Sex Transm Dis 2007;34:145-6.
43. Ghanem KG, Moore RD, Rompalo AM, et al. Lumbar puncture in HIV-infected patients with syphilis and no neurologic symptoms. Clin Infect Dis 2009;48:816-21.
44. Stoner BP. Current controversies in the management of adult syphilis. Clin Infect Dis 2007;44(Suppl 3):S130-46.
45. Dowell D, Polgreen PM, Beekmann SE, et al. Dilemmas in the management of syphilis: a survey of infectious diseases experts. Clin Infect Dis 2009;49:1526-9.
46. Gross PA. When guidelines don't guide the physician. Clin Infect Dis 2009;49:1530-1.
47. Centers for Disease Control and Prevention. Sexually transmitted disease surveillance, 2008. Atlanta, GA: Department of Health and Human Services, 2009.